Jumpei Terakawa

Dr. Jumpei Terakawa

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
SKSatoshi Kofuji
Satoshi Kofuji
AHAkiyoshi Hirayama
Akiyoshi Hirayama
AEAlexander Otto Eberhardt
Alexander Otto Eberhardt
RKRisa Kawaguchi
Risa Kawaguchi
YSYuki Sugiura
Yuki Sugiura
ASAtsuo T. Sasaki
Atsuo T. Sasaki

1 July 2014 in Endocrinology
Verified
Journal Article
Closed access
TDTakiko Daikoku
Takiko Daikoku
YOYuya Ogawa
Yuya Ogawa
JTJumpei Terakawa
Jumpei Terakawa
AOAkiyo Ogawa
Akiyo Ogawa
TDTony DeFalco
Tony DeFalco
SDSudhansu K. Dey
Sudhansu K. Dey
Transgenic animal models are valuable for studying gene function in various tissue compartments. Mice with conditional deletion of genes in the uterus using the Cre-loxP system serve as powerful tools to study uterine biology. The uterus is comprised of 3 major tissue types: myometrium, stroma, and epithelium. Proliferation and differentiation in each uterine cell type are differentially regulated by ovarian hormones, resulting in spatiotemporal control of gene expression. Therefore, examining gene function in each uterine tissue type will provide more meaningful information regarding uterine biology during pregnancy and disease states. Although currently available Cre mouse lines have been very useful in exploring functions of specific genes in uterine biology, overlapping expression of these Cre lines in more than 1 tissue type and in other reproductive organs sometimes makes interpretation of results difficult. In this article, we report the generation of a new iCre knock-in mouse line, in which iCre is expressed from endogenous lactoferrin (Ltf) promoter. Ltf-iCre mice primarily direct recombination in the uterine epithelium in adult females and in immature females after estrogen treatment. These mice will allow for specific interrogation of gene function in the mature uterine epithelium, providing a helpful tool to uncover important aspects of uterine biology.

1 January 2016 in Molecular Cell
Verified
Journal Article
Closed access
KSKazutaka Sumita
Kazutaka Sumita
YLYu-Hua Lo
Yu-Hua Lo
KTKoh Takeuchi
Koh Takeuchi
MSMiki Senda
Miki Senda
SKSatoshi Kofuji
Satoshi Kofuji
ASAtsuo T. Sasaki
Atsuo T. Sasaki

1 February 2008 in Emerging Infectious Diseases
Verified
Journal Article
Open access
KMKen Maeda
Ken Maeda
EHEiichi Hondo
Eiichi Hondo
JTJumpei Terakawa
Jumpei Terakawa
YKYasuo Kiso
Yasuo Kiso
NNNumekazu Nakaichi
Numekazu Nakaichi
TMTetsuya Mizutani
Tetsuya Mizutani
Isolation of Novel Adenovirus from Fruit Bat (Pteropus dasymallus yayeyamae)

1 July 2016 in Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
JTJumpei Terakawa
Jumpei Terakawa
ARAltea Rocchi
Altea Rocchi
VSVanida A. Serna
Vanida A. Serna
EBErwin P. Bottinger
Erwin P. Bottinger
JGJonathan M. Graff
Jonathan M. Graff
TKTakeshi Kurita
Takeshi Kurita
Cell fate of lower Müllerian duct epithelium (MDE), to become uterine or vaginal epithelium, is determined by the absence or presence of ΔNp63 expression, respectively. Previously, we showed that SMAD4 and runt-related transcription factor 1 (RUNX1) were independently required for MDE to express ΔNp63. Here, we report that vaginal mesenchyme directs vaginal epithelial cell fate in MDE through paracrine activation of fibroblast growth factor (FGF) receptor-MAPK pathway. In the developing reproductive tract, FGF7 and FGF10 were enriched in vaginal mesenchyme, whereas FGF receptor 2IIIb was expressed in epithelia of both the uterus and vagina. When Fgfr2 was inactivated, vaginal MDE underwent uterine cell fate, and this differentiation defect was corrected by activation of MEK-ERK pathway. In vitro, FGF10 in combination with bone morphogenetic protein 4 and activin A (ActA) was sufficient to induce ΔNp63 in MDE, and ActA was essential for induction of RUNX1 through SMAD-independent pathways. Accordingly, inhibition of type 1 receptors for activin in neonatal mice induced uterine differentiation in vaginal epithelium by down-regulating RUNX1, whereas conditional deletion of Smad2 and Smad3 had no effect on vaginal epithelial differentiation. In conclusion, vaginal epithelial cell fate in MDE is induced by FGF7/10-MAPK, bone morphogenetic protein 4-SMAD, and ActA-RUNX1 pathway activities, and the disruption in any one of these pathways results in conversion from vaginal to uterine epithelial cell fate.

1 January 2011 in Journal of Reproduction and Development
Verified
Journal Article
Open access
PDF file
JTJumpei Terakawa
Jumpei Terakawa
SWShoichi Wakitani
Shoichi Wakitani
MSMakoto Sugiyama
Makoto Sugiyama
NINaoko Inoue
Naoko Inoue
YOYasushige Ohmori
Yasushige Ohmori
EHEiichi Hondo
Eiichi Hondo
Leukemia inhibitory factor (LIF) is essential for embryo implantation in mice and plays an important role in other mammals including humans. Intraperitoneal (ip) injections with anti-LIF antibody (7.5 μg/g body weight, 3 times) between D3 (D1 = day of vaginal plug detection) and D4 effectively blocked embryo implantation; complete inhibition was achieved in C57BL/6J mice, and implantation was dramatically reduced in ICR mice (reduced to 27%). Normal rabbit IgG used as the control did not disturb embryo implantation. Anti-LIF antibody was localized not only in the stroma, but also in the luminal epithelium and the glandular lumen after ip injections. Growth-arrested blastocysts were recovered from the uterus without any implantation sites in both strains. Blastocysts made contact with the LE on the antimesometrial side; however, uterine stromal cells did not undergo secondary decidual reaction, and the uterine lumen was open, even at D7. Several regions of decidualization in ICR mice treated with anti-LIF antibody were smaller than those of the control, and development of blastocysts was delayed. The expression of LIF-regulated genes, such as immune-responsive gene-1 and insulin-like growth factor binding protein-3, was significantly decreased in C57BL/6J mice treated with anti-LIF antibody compared with the control, but not in ICR mice. The present study demonstrated that simple ip injections of an antibody are sufficient to block one of the important factors involved in embryo implantation in mice, and this method should also be easily applicable to the investigation of other factors involved in implantation.